Hepatitis B is a viral infection that attacks the liver and can range from a brief illness lasting a few weeks to a serious, lifelong condition. An estimated 250 to 300 million people worldwide live with chronic hepatitis B, and many don’t know they’re infected because the virus can silently damage the liver for years without causing obvious symptoms. The good news: a highly effective vaccine prevents it, and antiviral treatments can control chronic infections.
How the Virus Infects the Liver
Hepatitis B virus (HBV) belongs to a family called hepadnaviruses. It targets liver cells specifically. Once the virus enters a liver cell, it releases its DNA into the cell’s nucleus, where it forms a stable, ring-shaped piece of genetic material. This ring acts as a template, hijacking the cell’s own machinery to produce new copies of the virus. Those copies are then assembled inside the cell and released into the bloodstream, where they go on to infect more liver cells.
What makes HBV especially persistent is that the ring-shaped DNA template is difficult for the immune system to eliminate. Even when antiviral treatment suppresses the virus to undetectable levels in the blood, this template can linger in liver cells, which is why chronic hepatitis B requires long-term management rather than a simple cure.
How Hepatitis B Spreads
HBV spreads through blood and bodily fluids, including semen and vaginal secretions. The most common routes of transmission are:
- Birth: an infected mother passing the virus to her newborn during delivery
- Sexual contact: unprotected sex with an infected person
- Shared needles or syringes: including during injection drug use or unsterilized medical equipment
- Direct blood contact: through open wounds, shared razors, or toothbrushes contaminated with infected blood
One detail that surprises many people: HBV can survive on environmental surfaces for at least seven days. A dried spot of infected blood on a countertop or razor that looks harmless can still transmit the virus if it enters a cut or mucous membrane. This makes hepatitis B far more resilient outside the body than HIV, which survives only hours on surfaces.
Symptoms of Acute Infection
Acute hepatitis B refers to the first six months after exposure. Up to half of older children, adolescents, and adults develop noticeable symptoms during this phase, though most children under five show none at all. When symptoms do appear, they typically include fatigue, fever, joint pain, loss of appetite, nausea, stomach pain, and vomiting. Dark urine, clay-colored stools, and yellowing of the skin or eyes (jaundice) are the more recognizable signs.
Symptoms usually show up two to three months after exposure, though the window can range from six weeks to six months. Most healthy adults who develop acute hepatitis B clear the virus on their own within a few months and develop lasting immunity. The real concern is what happens when the virus doesn’t clear.
When It Becomes Chronic
Chronic hepatitis B means the virus remains in the body for six months or longer. Age at infection is the biggest factor in whether this happens. About 90% of infants infected at birth develop chronic infection, compared to roughly 5% of healthy adults. This is why newborn vaccination is so critical.
Many people with chronic hepatitis B feel perfectly fine for years or even decades. The virus is still active in the liver, though, causing low-grade inflammation that gradually damages liver tissue. Over time, this silent damage can lead to serious complications. In a 10-year study of 673 patients with chronic hepatitis B, 16.2% developed cirrhosis (severe scarring of the liver) and 7.8% developed liver cancer. Among those who already had cirrhosis, the liver cancer rate jumped to 29.7% over 10 years, with the highest risk occurring within the first year of a cirrhosis diagnosis.
These numbers underscore why ongoing monitoring matters even when you feel well.
How Hepatitis B Is Diagnosed
Hepatitis B is diagnosed through blood tests that look for specific viral markers. The CDC now recommends that all adults aged 18 and older get screened at least once in their lifetime using a three-test panel. This panel checks for:
- Surface antigen (HBsAg): a protein on the virus’s outer shell. A positive result means you currently have an active infection, either acute or chronic.
- Surface antibody (anti-HBs): produced by your immune system in response to the virus or to vaccination. A positive result means you’re immune.
- Core antibody (total anti-HBc): indicates you’ve been exposed to the virus at some point. This marker stays positive for life, even after you’ve cleared the infection.
The combination of these three results tells the full picture. Someone who tests positive only for the surface antibody was likely vaccinated and is protected. Someone positive for the surface antigen and core antibody but negative for the surface antibody has an active infection. If the surface antigen remains positive for six months or more, the infection is classified as chronic.
Treatment for Chronic Hepatitis B
Not everyone with chronic hepatitis B needs immediate treatment. Doctors typically recommend starting antiviral therapy when there are signs of active liver disease, significant viral replication, or early liver damage. The goal of treatment is to suppress the virus to protect the liver, not necessarily to eliminate it entirely (which current medications rarely achieve).
The primary treatments are oral antiviral medications taken once daily, usually for at least a year and often indefinitely. Three options are considered first-line choices because of their strong effectiveness and very low rates of drug resistance: entecavir (approved in 2005), tenofovir disoproxil (2008), and tenofovir alafenamide (2016). All three have relatively few side effects for most people. An older injectable treatment exists but is used less frequently because it causes more side effects, including flu-like symptoms and depression.
For people on treatment, regular blood work monitors viral levels and liver function. Many patients on antiviral therapy achieve undetectable virus levels in the blood, which dramatically reduces the risk of cirrhosis and liver cancer, though it doesn’t eliminate that risk completely. Stopping medication without medical guidance can cause a dangerous flare of liver inflammation, so any changes to treatment should be managed carefully.
Vaccination and Prevention
The hepatitis B vaccine is the most effective way to prevent infection. The standard schedule involves three doses, and studies indicate that immunity lasts at least 30 years when vaccination begins in infancy. The vaccine is recommended for all newborns (ideally within 24 hours of birth), all children and adolescents who weren’t vaccinated earlier, and adults aged 19 to 59. Adults 60 and older can also receive the vaccine if they have risk factors or simply want protection.
For newborns born to mothers with hepatitis B, receiving the vaccine along with a dose of hepatitis B immune globulin within 12 hours of birth is over 90% effective at preventing the baby from becoming chronically infected. This combination has been one of the most impactful public health interventions in reducing mother-to-child transmission worldwide.
Beyond vaccination, prevention comes down to avoiding contact with infected blood and bodily fluids: using condoms, not sharing needles or personal items like razors and toothbrushes, and ensuring any tattoo or piercing equipment is properly sterilized.
Living with Chronic Hepatitis B
A chronic hepatitis B diagnosis is not a death sentence, but it does require attention. Regular monitoring, typically every six months, includes blood tests to check viral activity and liver function, along with imaging or other screening for liver cancer. People with cirrhosis need more frequent cancer surveillance because their annual risk of developing liver cancer is roughly 3%.
Alcohol accelerates liver damage significantly in people with hepatitis B, so minimizing or eliminating alcohol intake is one of the most impactful steps you can take. Maintaining a healthy weight also matters, since fatty liver disease layered on top of hepatitis B compounds the strain on the liver. Some over-the-counter medications and herbal supplements can be toxic to the liver, so it’s worth reviewing anything you take regularly with a provider who knows your hepatitis B status.
People with chronic hepatitis B can live full, active lives. The virus is not spread through casual contact like hugging, sharing food, coughing, or sneezing. You don’t need separate dishes or utensils. With consistent monitoring and, when needed, antiviral treatment, the serious complications of hepatitis B are largely preventable.